生物标志物 生物标志物
Grace Austin1, Shaun Eslick1, Jessica Ferguson2
1Macquarie University, Macquarie Park, NSW, Australia.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 25, 2025
概括
更高的心血管疾病 (CVD) 风险与增加的神经纤维光链 (NFL) 水平有关,这是神经退行症的标志物. 这表明心血管健康可能会影响大脑健康和阿尔茨海默病 (AD) 途径.
科学领域:
- 神经科学是一个神经科学.
- 心脏病学 心脏病学
- 生物标志物研究 生物标志物研究
背景情况:
- 可修改的心血管疾病 (CVD) 风险因素与阿尔茨海默病 (AD) 病原发生有关.
- 这些因素可能会通过血管机制导致认知衰退和AD病理.
- 在认知上正常的个体中,CVD风险和血AD生物标志物之间的关联存在有限的研究.
研究的目的:
- 为了研究预测心血管疾病 (CVD) 风险和血阿尔茨海默病 (AD) 生物标志物之间的关联.
- 为了确定心血管疾病风险是否与血液中的特定AD相关蛋白质有关.
主要方法:
- 对237名澳大利亚成年人 (30-75岁) 的横截面分析.
- 使用已确定的方程计算5年和10年心血管疾病风险得分.
- 使用SIMOA试验测量血AD生物标志物 (Aβ1-40,Aβ1-42,GFAP,NFL,pTau181) 的结果.
- 对年龄和性别进行调整的部分相关性分析.
主要成果:
- 预测较高的5年和10年心血管疾病风险与神经纤维光链 (NFL) 水平显著正相关 (r=0.22-0.23,p<0.001).
- 在心血管疾病风险和GFAP,Aβ42/40比率或pTau181.1.之间没有发现显著的相关性.
- 没有观察到心脏代谢风险变量与其他AD生物标志物之间的显著相关性.
结论:
- 心血管疾病风险升高与NFL增加有关,NFL是一种神经退行生物标志物,独立于年龄和性别.
- 这表明心血管风险因素可能会显著影响神经退行性途径.
- 需要进一步的纵向研究来探索心血管疾病风险和AD生物标志物之间的复杂相互作用.
相关概念视频
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
746
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
746
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
511
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
511


